Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer

H. Kusumoto, Y. Maehara, M. Yoshida, I. Takahashi, H. Anai, K. Sugimachi

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

The in vitro drug sensitivity of gastric cancer tissues obtained from 40 patients with advanced cancer was compared in terms of the pathological classifications which were assigned according to the General Rules for the Gastric Cancer Study in Surgery and Pathology in Japan. Cases of poorly differentiated adenocarcinoma which had penetrated the serosa were evaluated using the succinate dehydrogenase inhibition (SDI) test for determining the in vitro chemosensitivity. The sensitivity of the stage III group to cisplatin was higher than that of the stage IV group. Although there were no statistical differences in drug sensitivities according to macroscopic findings (Borrmann's classification), the expanding growth type was more susceptible than the infiltrating type to cisplatin, aclacinomycin A (ACR) and carboquone (CQ) microscopically. In cases of lymph node metastasis [n(+)] the sensitivity to cisplatin, ACR, CQ, adriamycin and mitomycin C was less than in those with or without primary lymph node metastasis [n(-)]; lymphatic invasion in the gastric wall (ly) was a significant factor linked to drug resistance. Our findings indicate that the evaluation of tumor pathology is important in predicting the chemosensitivity of poorly differentiated gastric cancers.

Original languageEnglish
Pages (from-to)33-38
Number of pages6
JournalAnti-cancer drugs
Volume3
Issue number1
DOIs
Publication statusPublished - 1992

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Cancer Research

Fingerprint Dive into the research topics of 'Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer'. Together they form a unique fingerprint.

Cite this